Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: Effect of standardized guidelines on prescribing practice

Archives of Internal Medicine

Volumn 170, Issue 9, 2010, Pages 779-783

  Yachimski, Patrick S ^a,b   Farrell, Elizabeth A ^a   Hunt, Daniel P ^a   Reid, Andrea E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; AGE; AGED; ARTICLE; FEMALE; GASTROESOPHAGEAL REFLUX; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; UPPER GASTROINTESTINAL BLEEDING;

BOSTON; FEMALE; GASTROINTESTINAL HEMORRHAGE; GUIDELINE ADHERENCE; HUMANS; INPATIENTS; LOGISTIC MODELS; MALE; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS;

EID: 77952126952     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.51     Document Type: Article

References (22)

1. Cook DJ, Fuller HD, Guyatt GH, et al; Canadian Critical Care Trials Group. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med. 1994;330(6):377-381.
2. Cook D, Guyatt G, Marshall J, et al; Canadian Critical Care Trials Group. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998;338(12):791-797.
3. Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol. 2006;101(10):2200-2205.
4. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000;95(11):3118-3122.
5. Pham CQ, Regal RE, Bostwick TR, Knauf KS. Acid suppressive therapy use on an inpatient internal medicine service. Ann Pharmacother. 2006;40(7-8):1261- 1266.
6. Zink DA, Pohlman M, Barnes M, Cannon ME. Long-term use of acid suppression started inappropriately during hospitalization. Aliment Pharmacol Ther. 2005;21(10):1203-1209. (Pubitemid 40733485)
7. Insogna KL. The effect of proton pump-inhibiting drugs on mineral metabolism. Am J Gastroenterol. 2009;104(suppl 2):S2-S4.
8. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296(24):2947-2953. (Pubitemid 46021498)
9. Dial MS. Proton pump inhibitor use and enteric infections. Am J Gastroenterol. 2009;104(suppl 2):S10-S16.
10. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294(23):2989-2995. (Pubitemid 41817660)
11. Aseeri M, Schroeder T, Kramer J, Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol. 2008;103(9):2308-2313.
12. Dalton BR, Lye-Maccannell T, Henderson EA,Maccannell DR, Louie TJ. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a lowendemicity, non-outbreak hospital setting. Aliment Pharmacol Ther. 2009;29(6):626-634.
13. Vakil N. Acid inhibition and infections outside the gastrointestinal tract. Am J Gastroenterol. 2009;104(suppl 2):S17-S20.
14. Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med. 2008;149(6):391-398.
15. Miano TA, Reichert MG, Houle TT, MacGregor DA, Kincaid EH, Bowton DL. Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients. Chest. 2009;136(2):440-447.
16. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medications and the risk of hospital-acquired pneumonia. JAMA. 2009;301(20):2120-2128.
17. Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009;301(9):937-944.
18. van Vliet EP, Otten HJ, Rudolphus A, et al. Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards. Eur J Gastroenterol Hepatol. 2008;20(7):608-612.
19. Barada K, Karrowni W, Abdallah M, Shamseddeen W, Sharara AI, Dakik HA. Upper gastrointestinal bleeding in patients with acute coronary syndromes: clinical predictors and prophylactic role of proton pump inhibitors. J Clin Gastroenterol. 2008;42(4):368-372. (Pubitemid 351450621)
20. Glew CM, Rentler RJ. Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients. J Am Med Dir Assoc. 2007;8(9):607-609.
21. Smeets HM, Hoes AW, de Wit NJ. Effectiveness and costs of implementation strategies to reduce acid suppressive drug prescriptions: a systematic review. BMC Health Serv Res. 2007;7:e177. http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2204001/?tool=pubmed. Accessed February 8, 2010.
22. Mollon B, Chong J Jr, Holbrook AM, Sung M, Thabane L, Foster G. Features predicting the success of computerized decision support for prescribing: a systematic review of randomized controlled trials. BMD Med Inform Decis Mak. 2009;9:e11. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667396/?tool=pubmed. Accessed February 9, 2010.